Society for Maternal-Fetal Medicine, 409 12th St., SW, Washington, DC 20024.
Semin Perinatol. 2013 Oct;37(5):292-4. doi: 10.1053/j.semperi.2013.06.003.
There is currently a lack of published data on ultrasound utilization in obstetrics in the United States. In order to get some meaningful information on this topic, we analyzed de-identified data obtained from large insurance providers and underwriters that covered large segment of the United States population in various geographic areas of the country. Our results show an overall significant increase in utilization of obstetric ultrasound over the years, with pregnancies receiving around 4-5 ultrasounds per pregnancy. Another important aspect of the data is a higher than expected utilization of the targeted 76811 ultrasound examination, with utilization rates between 30% and 50%, beyond the original intention of the targeted code. Despite the fact that the data was not intended to shed light on indication of ultrasound or competency of ultrasound providers, in a healthcare world of shrinking reimbursement, as leaders of quality, we should ensure that ultrasound examinations that pregnant women receive are indicated and are performed by competent healthcare workers in ultrasound laboratories that meet accreditation standards.
目前，美国在妇产科中使用超声的相关数据还比较缺乏。为了获取关于这个主题的一些有意义的信息，我们分析了从大型保险公司和承销商那里获得的匿名数据，这些数据覆盖了美国不同地区的大部分人口。我们的研究结果表明，多年来，妇产科超声的使用呈显著增加趋势，每次妊娠大约进行 4-5 次超声检查。数据的另一个重要方面是，目标为 76811 的超声检查的使用超出预期，使用率在 30%至 50%之间，超出了目标编码的初衷。尽管这些数据并非旨在说明超声检查的适应证或超声提供者的能力，但在医疗保健费用不断缩减的情况下，作为质量领导者，我们应该确保孕妇接受的超声检查是有适应证的，并由符合认证标准的超声实验室的有能力的医疗保健工作者进行。
